SHANGHAI, May 17, 2017 /PRNewswire/ -- An international team led by the iHuman Institute, ShanghaiTech University determined the molecular structure of the human glucagon-like peptide-1 receptor (GLP-1R). The results, described in the paper entitled "Human ... ( read original story ...)
Regional technology centre opens in Shanghai to address shipping emissions
Shanghai Maritime University has launched a new regional centre on Monday that will provide leadership in promoting ship energy efficiency and technologies and operations, and the reduction of harmful emissions from ships. The centre will cater to the ... ( read original story ...)
Shanghai Pharma weighs rival bid for Germany's Stada
Shanghai Pharma will need to move fast if it wants to outbid Bain and Cinven as any new offer has to be vetted by Germany's financial regulator BaFin. The German watchdog grants bidders a window of four weeks to hand in their official takeover documents ... ( read original story ...)
BRIEF-Zheshang Securities issues prospectus for Shanghai IPO
Source text in Chinese: bit.ly/2qlr2Xk (Reporting by Hong Kong newsroom) Our Standards: The Thomson Reuters Trust Principles Next In First Republic News ( read original story ...)
Shanghai aims to spur foreign trade
Shanghai aims to nurture foreign trade by channeling greater support for trading companies and local brands. Targeted services and incentives will be offered to 100 biggest foreign trading firms, 100 local brands and 100 new trading companies in the city ... ( read original story ...)
Shanghai Pharma confirms interest in Stada, says no official offer
SHANGHAI Chinese drugmaker Shanghai Pharmaceutical Holding Co Ltd said on Wednesday it was interested in a possible deal for Germany's Stada Arzneimittel AG, though it had not made any official offer. German drug firm Stada, the target of a takeover bid ... ( read original story ...)
Shanghai Pharma says may submit rival bid for Germany's Stada
SHANGHAI/LONDON/FRANKFURT Shanghai Pharmaceutical Holding Co ... was agreed on April 10 but was conditional on securing 75 percent of Stada's shares. Any new offer would trigger a separate offer period, which might run in parallel to the existing one. ( read original story ...)